HTF Market Intelligence released a new research report of 481 pages on title ‘Blood Glucose Meters – Medical Devices Pipeline Assessment, 2017’ with detailed analysis, forecast and strategies.
Blood Glucose Meters – Medical Devices Pipeline Assessment, 2017
GlobalData’s Medical Devices sector report, “Blood Glucose Meters – Medical Devices Pipeline Assessment, 2017″” provides an overview of Blood Glucose Meters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Meters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
– Extensive coverage of the Blood Glucose Meters under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to buy
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Blood Glucose Meters under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
companies Mentioned in the Report
4a Medicom GmbH
- Menarini Diagnostics S.r.l.
Abbott Diabetes Care, Inc.
Advanced Biosensors-Ohio, Llc
Advanced Medical Electronics Corporation
Arkal Medical, Inc.
Ascensia Diabetes Care Holdings AG
Azurite Technologies, Inc.
Bio-Impedance General Ltd.
BlueVine Graphene Industries, Inc.
Brigham and Women’s Hospital
CALISTO MEDICAL, INC.
Cell MedX Corp
City, University of London
ConvaTec Group Plc
Cyber Medical Ltd.
Echo Therapeutics Inc
Ecole Polytechnique Federale de Lausanne
eLutions Integrated Systems, Inc.
Emperra GmbH E-Health Technologies
Gili Medical Ltd
Globe Medical Tech Inc
Glucosense Diagnostics Ltd
GlucoStats System Pte Ltd.
Grove Instruments Inc.
Guided Therapeutics Inc
Indigo Diabetes NV
InLight Solutions Inc.
Institute of Biomedical Engineering (ISIB-CNR)
Integrated Medical Group of Irvine
Integrity Applications Ltd
Intuity Medical Inc
iXensor Co. Ltd.
Lein Applied Diagnostics Limited
LEMM Technologies, LLC
LighTouch Medical, Inc.
Luminous Medical Inc
M Pharmaceutical Inc
Massachusetts Institute of Technology
Medella Health Inc.
Medical Wireless Sensing Ltd
Microchips Biotech Inc
MIT Spectroscopy Lab
Nemaura Medical Inc
Newton Photonics Inc
NIR Diagnostics Inc.
Optiscan Biomedical Corp
Pelikan Technologies, Inc.
Pepex Biomedical, Inc.
Pop Test LLC
POPS! Diabetes Care Inc
Q Step Technologies, Inc.
Roche Diabetes Care Inc
Royal Adelaide Hospital SA
RSP Systems A/S
San Meditech (Huzhou) Co., Ltd.
SensiVida Medical Technologies, Inc.
Sensys Medical, Inc.
Sentec Pte Ltd
Sentek Group, Inc.
Singapore Biomicro Pte Ltd
Socrates Health Solutions, Inc.
St. Louis Medical Devices, Inc
Tenax Therapeutics Inc
Texas A&M University
Ultradian Diagnostics LLC
University of Bath
University of California Berkeley
University of California Irvine
University of California San Diego
University of Central Florida
University of Oxford
University of South Florida
University of Texas at Arlington
Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/337129-blood-glucose-meters-medical-devices-pipeline-assessment-2017
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 20
2 Introduction 21
2.1 Blood Glucose Meters Overview 21
3 Products under Development 22
3.1 Blood Glucose Meters – Pipeline Products by Stage of Development 22
3.2 Blood Glucose Meters – Pipeline Products by Segment 23
3.3 Blood Glucose Meters – Pipeline Products by Territory 24
3.4 Blood Glucose Meters – Pipeline Products by Regulatory Path 26
3.5 Blood Glucose Meters – Pipeline Products by Estimated Approval Date 27
3.6 Blood Glucose Meters – Ongoing Clinical Trials 28
4 Blood Glucose Meters – Pipeline Products under Development by Companies 29
4.1 Blood Glucose Meters Companies – Pipeline Products by Stage of Development 29
4.2 Blood Glucose Meters – Pipeline Products by Stage of Development 34
5 Blood Glucose Meters Companies and Product Overview 39
5.1 4a Medicom GmbH Company Overview 39
5.2 A. Menarini Diagnostics S.r.l. Company Overview 40
5.3 Abbott Diabetes Care, Inc. Company Overview 41
5.4 Advanced Biosensors-Ohio, Llc Company Overview 47
5.5 Advanced Medical Electronics Corporation Company Overview 48
5.6 AirMarkers Company Overview 49
5.7 Animas Corp Company Overview 50
5.8 Arkal Medical, Inc. Company Overview 52
5.9 Arkray Inc Company Overview 53
5.10 Ascensia Diabetes Care Holdings AG Company Overview 54
5.11 Azurite Technologies, Inc. Company Overview 56
5.12 Bar-Ilan University Company Overview 57
5.13 Baylor University Company Overview 58
5.14 Bio-Impedance General Ltd. Company Overview 59
5.15 Biopeak Corp Company Overview 60
5.16 Biorasis, Inc. Company Overview 61
5.17 BioTelemetry Inc Company Overview 62
5.18 BioTex Inc Company Overview 63
5.19 Biovotion AG Company Overview 64
5.20 BlueVine Graphene Industries, Inc. Company Overview 66
5.21 Brigham and Women’s Hospital Company Overview 68
5.22 CALISTO MEDICAL, INC. (Inactive) Company Overview 69
5.23 Cardiff University Company Overview 70
5.24 Cell MedX Corp Company Overview 71
5.25 CGM3 Ltd Company Overview 74
5.26 City, University of London Company Overview 75
5.27 Columbia University Company Overview 76
5.28 ConvaTec Group Plc Company Overview 77
5.29 Cyber Medical Ltd. Company Overview 78
5.30 DarioHealth Corp Company Overview 79
5.31 Debiotech SA Company Overview 81
5.32 DexCom Inc Company Overview 82
5.33 DiaMonTech GmbH Company Overview 87
5.34 DIRAmed LLC. Company Overview 89
5.35 DirectSens GmbH Company Overview 91
5.36 Echo Therapeutics Inc Company Overview 92
5.37 Ecole Polytechnique Federale de Lausanne Company Overview 95
5.38 eLutions Integrated Systems, Inc. Company Overview 96
5.39 Emperra GmbH E-Health Technologies Company Overview 97
5.40 EyeSense GmbH Company Overview 98
5.41 Flowsion A/S Company Overview 102
5.42 Gili Medical Ltd Company Overview 103
5.43 Globe Medical Tech Inc Company Overview 104
5.44 GlucoLight Corporation (Inactive) Company Overview 105
5.45 GlucoMe Ltd Company Overview 106
5.46 Glucometrix AG Company Overview 109
5.47 Glucosat Company Overview 110
5.48 Glucosense Diagnostics Ltd Company Overview 111
5.49 GlucoSet AS Company Overview 113
5.50 GlucoStats System Pte Ltd. Company Overview 114
5.51 Glucovation Inc Company Overview 116
5.52 GluMetrics Inc Company Overview 117
5.53 GlySens Inc Company Overview 118
5.54 GlySure Ltd Company Overview 122
5.55 Grove Instruments Inc. (Inactive) Company Overview 125
5.56 G-Sense Ltd. Company Overview 127
5.57 Guided Therapeutics Inc Company Overview 128
5.58 i360medical Limited Company Overview 129
5.59 iGlyko, Inc. Company Overview 130
5.60 Indigo Diabetes NV Company Overview 131
5.61 InLight Solutions Inc. Company Overview 132
5.62 Institute of Biomedical Engineering (ISIB-CNR) (Inactive) Company Overview 133
5.63 Insulet Corp Company Overview 134
5.64 Integrated Medical Group of Irvine Company Overview 135
5.65 Integrity Applications Ltd Company Overview 136
5.66 IntelliDx Inc Company Overview 141
5.67 Intuity Medical Inc Company Overview 142
5.68 Invivomon Inc (Inactive) Company Overview 143
5.69 Invivosense ASA (Inactive) Company Overview 144
5.70 iSense Corporation (Inactive) Company Overview 145
5.71 iXensor Co. Ltd. Company Overview 146
5.72 KeenCAT Technologies Company Overview 147
5.73 Lein Applied Diagnostics Limited Company Overview 148
5.74 LEMM Technologies, LLC Company Overview 149
5.75 LifeScan Inc Company Overview 150
5.76 LighTouch Medical, Inc. Company Overview 151
5.77 Luminous Medical Inc Company Overview 154
5.78 Lyte Labs Company Overview 155
5.79 M Pharmaceutical Inc Company Overview 156
5.80 Massachusetts Institute of Technology Company Overview 157
5.81 MASTInc Company Overview 159
5.82 Medella Health Inc. Company Overview 160
5.83 Medical Wireless Sensing Ltd Company Overview 161
5.84 Medtronic plc Company Overview 162
5.85 Mellitor Ltd. Company Overview 172
5.86 Microchips Biotech Inc Company Overview 173
5.87 MIT Spectroscopy Lab Company Overview 174
5.88 mobiLIFE Company Overview 175
5.89 Nagasaki University Company Overview 176
5.90 Nemaura Medical Inc Company Overview 177
5.91 Newton Photonics Inc Company Overview 179
5.92 NIR Diagnostics Inc. (Inactive) Company Overview 180
5.93 Northwestern University Company Overview 181
5.94 NovioSense BV Company Overview 182
5.95 Optiscan Biomedical Corp Company Overview 183
5.96 Pelikan Technologies, Inc. (Inactive) Company Overview 188
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/337129-blood-glucose-meters-medical-devices-pipeline-assessment-2017
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=337129
CRAIG FRANCIS (PR & Marketing Manager)
Ph: +1 (206) 317 1218